Cite

HARVARD Citation

    Lin, C. et al. (2020). Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib. Cancer letters. pp. 81-96. [Online]. 
  
Back to record